Sandra Milligan
President bei ASPIRA WOMEN'S HEALTH INC.
Vermögen: 575 421 $ am 31.03.2024
Profil
Frau Sandra Milligan ist ein unabhängiges Mitglied des Verwaltungsrats bei Gossamer Bio, Inc. und Leiterin Forschung & Entwicklung bei Organon & Co. Sie ist Mitglied des Board of Directors bei Gossamer Bio, Inc. Frau Milligan war zuvor als Vice President-Regulatory Affairs bei Genentech, Inc. beschäftigt. Sie erhielt ihren Bachelor-Abschluss von der University of California, Irvine, einen Graduate-Abschluss vom Georgetown University Law Center und einen Doktortitel von der George Washington University School of Medicine & Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ORGANON & CO.
0,01% | 04.05.2023 | 28 599 ( 0,01% ) | 537 661 $ | 31.03.2024 |
GOSSAMER BIO, INC.
0,01% | 15.11.2023 | 32 000 ( 0,01% ) | 37 760 $ | 31.03.2024 |
Aktive Positionen von Sandra Milligan
| Unternehmen | Position | Beginn |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 10.06.2021 |
| ASPIRA WOMEN'S HEALTH INC. | President | 01.04.2024 |
Ehemalige bekannte Positionen von Sandra Milligan
| Unternehmen | Position | Ende |
|---|---|---|
| ORGANON & CO. | Chief Tech/Sci/R&D Officer | 01.01.2024 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01.04.2020 |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Director/Board Member | 01.01.2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2015 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Sandra Milligan
| University of California, Irvine | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
| The United States Army Medical Service Corps |
